Comparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial Cancers

被引:46
作者
Felix, Ashley Sinclair [1 ,2 ]
Stone, Roslyn A. [3 ]
Bowser, Robert [6 ]
Chivukula, Mamatha [4 ]
Edwards, Robert P. [5 ]
Weissfeld, Joel L. [1 ,2 ]
Linkov, Faina [1 ,2 ]
机构
[1] Univ Pittsburgh, Inst Canc, Div Canc Prevent & Populat Sci, Pittsburgh, PA 15232 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15232 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15232 USA
[4] UPMC Hlth Syst, Magee Womens Hosp, Dept Pathol, Pittsburgh, PA USA
[5] UPMC Hlth Syst, Magee Womens Hosp, Dept Obstet & Gynecol Oncol, Pittsburgh, PA USA
[6] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15232 USA
基金
美国国家卫生研究院;
关键词
Mortality; Aggressive endometrial cancers; Carcinosarcoma; PROGNOSTIC-FACTORS; UTERINE CARCINOSARCOMA; METAPLASTIC CARCINOMAS; GYNECOLOGIC CANCER; ADJUVANT THERAPY; UTERUS; RECURRENCE; VARIABLES; PATTERNS;
D O I
10.1097/IGC.0b013e31821a62dd
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Malignant mixed mullerian tumors (MMMTs) are an aggressive subtype of endometrial cancer (EC). Previous studies compare survival between high-grade endometrioid (EM), clear cell (CC), and papillary serous (PS) ECs; yet few studies compare MMMTs to these aggressive subtypes. The goal of this study was to compare recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) among EC subtypes. Methods: We conducted a retrospective cohort study of EC cases treated at Magee-Women's Hospital between 1996 and 2008. Kaplan-Meier estimates of RFS, DSS, and OS as well as and log-rank tests were used to compare survival distributions between histologic subtypes. Cox regression was used to estimate hazard ratios for histologic subtypes, adjusted for other significant prognostic factors. Interactions between histologic subtype and prognostic factors were examined to assess effect modification. Results: This cohort included 81 MMMT (15%), 254 high-grade EM (46%), 73 CC (13%), and 147 PS (26%) cases. Compared to high-grade EM (6%) and CC (7%) cases, relatively more MMMT (12%) and PS (12%) cases were nonwhite. Stage differed significantly among the subtypes, with 36%, 34%, 37%, and 51% of MMMT, high-grade EM, CC, and PS cases, respectively, diagnosed at advanced late stage (P < 0.001). Kaplan-Meier curves and log-rank tests showed similar RFS, DSS, and OS between MMMT, high-grade EM, CC, and PS cases stratified by stage. In adjusted Cox regression models, RFS and DSS were not significantly different between MMMT and other subtypes. High-grade EM cases had a significantly better OS compared to MMMT cases (HR, 0.63; 95% confidence interval [CI], 0.41-0.98). Conclusions: This is the first retrospective study to suggest that certain survival outcomes are similar among MMMT, high-grade EM, CC, and PS subtypes. Other large-scale studies are needed to confirm these findings.
引用
收藏
页码:877 / 884
页数:8
相关论文
共 28 条
[1]   Uterine carcinosarcomas and grade 3 endometrioid cancers - Evidence for distinct tumor behavior [J].
Bansal, Nisha ;
Herzog, Thomas J. ;
Seshan, Venkatraman E. ;
Schiff, Peter B. ;
Burke, William M. ;
Cohen, Carmel J. ;
Wright, Jason D. .
OBSTETRICS AND GYNECOLOGY, 2008, 112 (01) :64-70
[2]   A Clinical and Biological Comparison Between Malignant Mixed Mullerian Tumors and Grade 3 Endometrioid Endometrial Carcinomas [J].
Bland, Amy E. ;
Stone, Rebecca ;
Heuser, Cara ;
Shu, Jianfen ;
Jazaeri, Amir ;
Shutter, Jamie ;
Atkins, Kristin ;
Rice, Laurel .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (02) :261-265
[3]   Malignant mixed Mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome [J].
Callister, M ;
Ramondetta, LM ;
Jhingran, A ;
Burke, TW ;
Eifel, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03) :786-796
[4]   Uterine sarcomas: A review [J].
D'Angelo, Emanuela ;
Prat, Jaime .
GYNECOLOGIC ONCOLOGY, 2010, 116 (01) :131-139
[5]  
DINH TV, 1989, OBSTET GYNECOL, V74, P388
[6]   Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma [J].
Galaal, K. ;
Kew, F. M. ;
Tam, K. F. ;
Lopes, A. ;
Meirovitz, M. ;
Naik, R. ;
Godfrey, K. A. ;
Hatem, M. H. ;
Edmondson, R. J. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 143 (02) :88-92
[7]   Ovarian and Uterine Carcinosarcomas A Comparative Analysis of Prognostic Variables and Survival Outcomes [J].
Garg, Gunjal ;
Shah, Jay P. ;
Kumar, Sanjeev ;
Bryant, Christopher S. ;
Munkarah, Adnan ;
Morris, Robert T. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) :888-894
[8]   MALIGNANT MIXED MULLERIAN TUMOR VERSUS HIGH-GRADE ENDOMETRIAL CARCINOMA AND AGGRESSIVE VARIANTS OF ENDOMETRIAL CARCINOMA - A COMPARATIVE-ANALYSIS OF SURVIVAL [J].
GEORGE, E ;
LILLEMOE, TJ ;
TWIGGS, LB ;
PERRONE, T .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1995, 14 (01) :39-44
[9]  
Iwasa Y, 1998, CANCER-AM CANCER SOC, V82, P512, DOI 10.1002/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.0.CO
[10]  
2-4